IMMUNOTHERAPY FOR STEWART-TREVES SYNDROME - USEFULNESS OF INTRAPLEURAL ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES AGAINST MASSIVE PLEURAL EFFUSION CAUSED BY METASTATIC ANGIOSARCOMA

Citation
M. Furue et al., IMMUNOTHERAPY FOR STEWART-TREVES SYNDROME - USEFULNESS OF INTRAPLEURAL ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES AGAINST MASSIVE PLEURAL EFFUSION CAUSED BY METASTATIC ANGIOSARCOMA, Journal of the American Academy of Dermatology, 30(5), 1994, pp. 899-903
Citations number
19
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
01909622
Volume
30
Issue
5
Year of publication
1994
Part
2
Supplement
S
Pages
899 - 903
Database
ISI
SICI code
0190-9622(1994)30:5<899:IFSS-U>2.0.ZU;2-B
Abstract
We describe a 56-year-old woman with Stewart-Treves syndrome who had s evere dyspnea from a pleural effusion caused by metastatic angiosarcom a in the right lung. Tumorinfiltrating lymphocytes (TIL) in the pleura l effusion were cultured and expanded in vitro in the continuous prese nce of recombinant interleukin 2 with periodic stimulation by CD3 anti body. The expanded TIL were administered intrapleurally seven times at 1- to 4-week intervals in combination with intravenous infusion of re combinant interleukin 2. A panel of T-cell clones was also obtained fr om TIL. Immunotherapy dramatically improved the patient's dyspnea and pleural effusion. A CD4(+) T-cell clone and a CD8(+) T-cell clone esta blished from TIL had specific cytotoxicity to the tumor cells.